These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum]. Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529 [TBL] [Abstract][Full Text] [Related]
7. The effect of education on physicians' knowledge of a laboratory test: the case of maternal serum alpha-fetoprotein screening. Holtzman NA; Faden RR; Leonard CO; Chase GA; Ulrich SR J Clin Ethics; 1991; 2(4):243-7; discussion 247-50. PubMed ID: 1725136 [No Abstract] [Full Text] [Related]
8. Maternal serum screening for neural tube defects and Down syndrome. Keith D Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964 [No Abstract] [Full Text] [Related]
9. Towards the prevention of neural tube defects. Brock DJ Clin Genet; 1989 Nov; 36(5):339-47. PubMed ID: 2480859 [TBL] [Abstract][Full Text] [Related]
10. [Screening for neural tube defects. Determination of serum alpha-fetoprotein in women in the 16th to 18th weeks of pregnancy]. Nørgaard-Pedersen B; Jacobsen JC Ugeskr Laeger; 1978 Oct; 140(41):2499-2504. PubMed ID: 80870 [No Abstract] [Full Text] [Related]
11. [Interlaboratory variation in the prenatal screening test for neural tube closing defects]. Braoudakis G; Marguerat P; Marazzi A; Gutzwiller F Soz Praventivmed; 1984; 29(4-5):207-8. PubMed ID: 6207680 [TBL] [Abstract][Full Text] [Related]
12. AFP-screening for all? Davies DP; Cole GF; Derbyshire F; Jones AJ Lancet; 1980 May; 1(8179):1195. PubMed ID: 6155577 [No Abstract] [Full Text] [Related]
13. Maternal serum alpha-fetoprotein screening in a provincial Health District. Woolfson J; Holt EM; Whyman AE; Mabbs DV Br J Obstet Gynaecol; 1979 Feb; 86(2):87-90. PubMed ID: 85461 [TBL] [Abstract][Full Text] [Related]
15. Selection and validation of alpha-fetoprotein assay kits for the screening of Down syndrome. Knight GJ; Haddow J; Palomaki GE; Haddow JE Am J Obstet Gynecol; 1987 Jun; 156(6):1557-9. PubMed ID: 2438936 [No Abstract] [Full Text] [Related]
16. Serum AFP screening for neural tube defects. Leonard CO Clin Obstet Gynecol; 1981 Dec; 24(4):1121-32. PubMed ID: 6174261 [No Abstract] [Full Text] [Related]
17. Maternal serum alpha-fetoprotein monitoring. Council on Scientific affairs. JAMA; 1982 Mar; 247(10):1478-81. PubMed ID: 6173496 [TBL] [Abstract][Full Text] [Related]
18. Serum alpha-feto protein screening for neural tube defects: some notes for programme evaluators. Mason ES; Clarke M J R Soc Health; 1986 Dec; 106(6):210-2. PubMed ID: 2433441 [No Abstract] [Full Text] [Related]
19. The use of maternal serum AFP in screening for neural tube defects. Brock DJ UCLA Forum Med Sci; 1978; 20():191-7. PubMed ID: 80861 [No Abstract] [Full Text] [Related]
20. Evaluation of four "kit" immunoassay methods for determination of alpha-fetoprotein in serum during pregnancy. Wong PY; Doran TA; Ho FF; Mee AV Clin Chem; 1979 Nov; 25(11):1905-8. PubMed ID: 91454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]